Navigation Links
Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market
Date:6/22/2012

LONDON, June 22, 2012 /PRNewswire/ -- Post the economic recession, the healthcare spending across Europe has never been adequate enough. This web conference will try to understand the challenges facing the European anaesthesia equipment and peripherals market.

Frost & Sullivan will host a complimentary web conference entitled "Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market", which will take place on Thursday 28th June 2012 at 2.00 pm BST. Research Analyst Akanksha Joshi has completed extensive analysis on the Anaesthesia Equipment and peripherals market. The research expert will lead a short teleconference about new findings that affect the market, followed by a live question-and-answer session.

Highlights of the web conference will include learning about the growth of the anaesthesia equipment and peripherals market, identifying the drivers and restraints and discussing approaches that can be used to curb challenges faced by the manufacturers.

To participate in this complimentary web conference, please email Janique Morvan, Corporate Communications at janique.morvan@frost.com, with your full contact details. Upon receipt of the above-mentioned information, a registration link will be emailed to you.

This web conference will benefit manufacturers and distributors of anaesthesia equipment and peripheral devices, by discussing the market trends and offering forward projections for the market.

"With the number of surgical procedures on the rise, the consumable demand is increasing. Hence, even with limited budgets, the hospitals' demand of disposable consumables is intensifying," observes Akanksha Joshi. "Thus innovative patient friendly technologies are spurring growth in the anaesthesia equipment and associated peripheral devices market."

To receive a link of the recorded web conference and / or further information on this rese
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Electronic Medical Records Progress from an Enterprise-Centric Solution to a Customer-Specific Application, Finds Frost & Sullivan
2. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
3. Frost & Sullivan: Developing Integration Capabilities Presents a Real Opportunity for Vendors in the European CIS Market
4. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
5. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
6. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
7. Frost & Sullivan Research Preview: Top 20 Telehealth Markets
8. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
11. U.S. News & World Report and Pharmacy Times Announce "Top Recommended Health Products"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... March 2, 2015 Cure SMA recently announced a ... Biomedical Research (CALIBR). This funding is an extension of a ... a $700,000 Cure SMA grant to Dr. Peter G. ... "Optimization of Small Molecules that Increase SMN2 Levels ... motor neuron (SMN) protein is critical to the function of ...
(Date:3/2/2015)... -- Landauer, Inc. (NYSE: LDR ), a recognized ... outsourced medical physics services and high quality medical consumable ... the fiscal first quarter 2015 after the market close ... Company will also host a conference call for investors ... Time (10:00 a.m. Eastern Time). Investors may access the ...
(Date:3/2/2015)... March 2, 2015 Amgen (NASDAQ: ... abstracts, including data evaluating Repatha TM (evolocumab), an ... investigational drug for chronic heart failure, at the upcoming ... Session (ACC.15), being held March 14-16 in ... fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin ...
Breaking Medicine Technology:Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 2Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 3Landauer, Inc. Announces Date and Time for Announcement of Fiscal First Quarter 2015 Results and Conference Call 2Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 2Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 3Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 4Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 5Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 6Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 7Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 8Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 9Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 10Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 11
... Most Up-to-Date Analysis of the Alzheimer,s Disease Market Now ... ... WALTHAM, Mass., July 15 Decision Resources, one ... and,healthcare issues, finds that with Myriad Genetics/Lundbeck,s decision to,discontinue ...
... for diseases of ... ... Pharmaceuticals, Inc.,a privately held biotechnology company located in San Jose, CA, ... from Penwest Pharmaceuticals, Edison,s development,partner. Penwest has begun dosing in a ...
Cached Medicine Technology:Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimer's Drug After Flurizan's Discontinuation 2Edison Pharma Hits Milestone as A0001 Enters Phase 1 Clinical Development 2
(Date:3/3/2015)... 03, 2015 AliCare Medical Management ... management programs and a member of the Amalgamated ... Julie O’Brien as President. O’Brien formerly served as ... In her new role, she will continue with ... of AMM’s call center operations, including clinical services, ...
(Date:3/3/2015)... Aureus Medical Group (web: aureuslocumtenens.com), a national ... that it will participate as an exhibitor at the ... 2015 in St. Louis, MO. , CareerMD Career Fairs ... and fellows in a comfortable, relaxed setting. , Representatives ... available to speak with attendees about its full range ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Calvary ... at their Brooklyn Satellite in Lutheran Medical Center, ... quarterly award must demonstrate excellence through clinical expertise ... also expected to go above and beyond to ... presence with patients and their families. Award recipients ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Cutler Integrative ... get to the root, gives cutting-edge tips to bring ... way to renew the body by first cleaning house. ... Naturopathic medicine, “We are all Toxic.” Between environmental toxins ... of potential greatness, and our high stress levels, we ...
(Date:3/2/2015)... A cocaine snorting Oscar statue ... typical nip slip or scathing scuffle. A new take ... the streets of Hollywood as Paper Jesus’ rendition of ... and substance abuse in Hollywood. The Oscar statue is ... political stance on the travails of drug addiction in ...
Breaking Medicine News(10 mins):Health News:Julie O'Brien Named President of AliCare Medical Management 2Health News:Julie O'Brien Named President of AliCare Medical Management 3Health News:Calvary Hospital Honors Peter Acerios, RN, with Daisy Award 2Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 3
... The AIUM is pleased to announce that ... endorse the recent AIUM Training Guidelines for the ... for a several practitioners, including physicians, osteopathic physicians, ... marking significant promise for the future of this ...
... heart trouble, study finds , TUESDAY, March 16 (HealthDay ... kick the habit, leading to a reduced risk of ... The study included more than 1,500 people taking part ... Before and one year after the participants stopped smoking, ...
... 16 The following is a statement from Charles Lyons , President and CEO of the Elizabeth Glaser Pediatric AIDS Foundation: , ... , , ... ... ...
... long been identified as a risk factor for cardiovascular disease ... at the University of Rochester Medical Center found that being ... of dying suddenly from cardiac causes. Scientists found that ... patients had a 76 percent increase in risk of ...
... found , TUESDAY, March 16 (HealthDay News) -- A ... early-stage lung tumors stable in patients who had inoperable ... the therapy, called stereotactic body radiation therapy (SBRT), were ... preliminary findings from a study published in the March ...
... diet as natural antioxidants is a good way forward for ... products. This has been shown by researchers from the Miguel ... place. Researchers from the Miguel Hernndez University have identified ... due to the fact they contain high levels of phenolic ...
Cached Medicine News:Health News:Unprecedented AIUM training guidelines speak to future of musculoskeletal ultrasound 2Health News:Blood Vessels Bounce Back Once Smokers Quit 2Health News:Elizabeth Glaser Pediatric AIDS Foundation President and CEO Charles Lyons Welcomes the Appointment of Anthony Lake as New Executive Director of UNICEF 2Health News:As girth grows, risk of sudden cardiac death shrinks 2Health News:As girth grows, risk of sudden cardiac death shrinks 3Health News:Radiation May Help Those With Inoperable Lung Tumors 2Health News:Radiation May Help Those With Inoperable Lung Tumors 3Health News:Cloves are the best natural antioxidant 2
... U.S. approval in 1992, ABIOMED's BVS 5000 has ... cardiac assist system in the world to support ... by the U.S. Food and Drug Administration for ... ABIOMED continues to make advances with the BVS ...
... Left Ventricular Assist System (LVAS), manufactured by ... used as a destination therapy for patients ... heart failure, for which heart transplantation is ... is not intended as a bridge to ...
... System includes three major components: Blood pump, ... Portable Driver. This system provides partial or ... with conventional therapy, is unable to maintain ... accomplish support, blood flows from the natural ...
Datascope presents a unique new product for post-hemostasis puncture site management. Safeguard is the first product ever to combine a built-in inflatable bulb and a sterile dressing- providing adjus...
Medicine Products: